English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
 
 
DownloadE-Mail
  A novel COL1A2 C-propeptide cleavage site mutation causing high bone mass osteogenesis imperfecta with a regional distribution pattern

Rolvien, T., Kornak, U., Stürznickel, J., Schinke, T., Amling, M., Mundlos, S., et al. (2018). A novel COL1A2 C-propeptide cleavage site mutation causing high bone mass osteogenesis imperfecta with a regional distribution pattern. Osteoporosis International, 29(1), 243-246. doi:10.1007/s00198-017-4224-8.

Item is

Files

show Files
hide Files
:
Rolvien.pdf (Publisher version), 3MB
Name:
Rolvien.pdf
Description:
-
OA-Status:
Visibility:
Public
MIME-Type / Checksum:
application/pdf / [MD5]
Technical Metadata:
Copyright Date:
-
Copyright Info:
© International Osteoporosis Foundation and National Osteoporosis Foundation 2017
License:
-

Locators

show
hide
Description:
-
OA-Status:

Creators

show
hide
 Creators:
Rolvien, T., Author
Kornak, U.1, 2, 3, Author           
Stürznickel, J., Author
Schinke, T., Author
Amling, M., Author
Mundlos, S.1, 2, 3, Author           
Oheim, R., Author
Affiliations:
1Research Group Development & Disease (Head: Stefan Mundlos), Max Planck Institute for Molecular Genetics, Max Planck Society, ou_1433557              
2Institute of Medical Genetics and Human Genetics, Charité-Universitätsmedizin Berlin, 13353, Berlin, Germany, ou_persistent22              
3Berlin-Brandenburg School for Regenerative Therapies, Charité-Universitätsmedizin Berlin, Berlin, Germany, ou_persistent22              

Content

show
hide
Free keywords: -
 Abstract: Osteogenesis imperfecta (OI) is typically characterized by low bone mass and increased bone fragility caused by heterozygous mutations in the type I procollagen genes (COL1A1/COL1A2). We report two cases of a 56-year-old woman and her 80-year-old mother who suffered from multiple vertebral and non-vertebral fractures with onset in early childhood. A full osteologic assessment including dual-energy X-ray absorptiometry (DXA), high-resolution peripheral quantitative computed tomography (HR-pQCT), and serum analyses pointed to a high bone mineral density (BMD) in the hip (DXA Z-score + 3.7 and + 3.9) but low to normal bone mass in the spine and preserved bone microstructure in the distal tibia. Serum markers of bone formation and bone resorption were elevated. Using whole exome sequencing, we identified a novel mutation in the COL1A2 gene causing a p. (Asp1120Gly) substitution at the protein level and affecting the type I procollagen C-propeptide cleavage site. In line with previously reported cases, our data independently prove the existence of an unusual phenotype of high bone mass OI caused by a mutation in the procollagen C-propeptide cleavage with a clinically persistent phenotype through adulthood.

Details

show
hide
Language(s): eng - English
 Dates: 2017-09-072017-09-152018-01
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Identifiers: DOI: 10.1007/s00198-017-4224-8
ISSN: 1433-2965 (Electronic) 0937-941X (Print)
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Osteoporosis International
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 29 (1) Sequence Number: - Start / End Page: 243 - 246 Identifier: -